US$ 28.97
glp-1 agonists for type 2 diabetes Clinical Focus on in Mellitus GLP-1 Receptor Agonists: A Game-Changer
Description
The introduction of an injectable GLP-1 has opened up new possibilities for patients with type 2 diabetes and obesity

J Neurosci Res (2011) 89:4819

Lingvay I, Desouza CV, Lalic KS, et al

JACC Heart failure (2023) 11(8 Pt 1):100010

Thrombus formation was more pronounced in mice transplanted with bone marrow deficient in functional GLP-1R (Glp1r/) compared to those with wild-type bone marrow, with these effects being dependent on nitric oxide [57]

*Livongo is now part of Teladoc Health, and we are in a brand transition phase
